This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Hammer, N. A Articles by Nielsen, F. C Search for Related Content PubMed PubMed Citation Articles by Hammer, N. A Articles by Nielsen, F. C

Expression of IGF-II mRNA-binding proteins (IMPs) in gonads and testicular cancer

¹ Departments of Clinical Biochemistry, ² Growth and Reproduction and ³ Laboratory of Reproductive Biology, Women and Reproduction, Rigshospitalet, Blegdamsvej 9, DK-2100 Copenhagen, Denmark, ⁴ Fertility Clinic, Hvidovre Hospital, Kettegård Allé 30, DK-2650 Hvidovre, Denmark, ⁵ Institute of Molecular Pathology, University of Copenhagen, Frederik V’s vej 11, DK-2100 Copenhagen, Denmark and ⁶ Institute of Molecular Biology, University of Copenhagen, DK-1307 Copenhagen, Denmark

Correspondence should be addressed to F C Nielsen; Email: fcn{at}rh.dk

Insulin-like growth factor-II mRNA-binding proteins 1, 2 and 3 (IMP1, IMP2 and IMP3) belong to a family of RNA-binding proteins implicated in mRNA localization, turnover and translational control. We examined their expression pattern during development of murine and human testis and ovaries. In the mouse, IMPs were expressed in male and female gonadal cells at embryonic day 12.5 (E12.5). From E16.5, IMP1 and IMP3 became restricted to the developing germ cells, whereas IMP2 expression persisted in the interstitial cells. In mature mouse and human ovaries, IMP1, IMP2 and IMP3 were detected in resting and growing oocytes and in the granulosa cells. In testis, IMP1 and IMP3 were found mainly in the spermatogonia, whereas IMP2 was expressed in the immature Leydig cells. Moreover, all three IMPs were detected in human semen. The developmental expression pattern of IMP1 and IMP3 in the human testis prompted us to examine their possible involvement in testicular neoplasia. IMPs were detected primarily in germ-cell neoplasms, including preinvasive testicular carcinoma in situ, classical and spermatocytic seminoma, and nonseminomas, with particularly high expression in undifferentiated embryonal carcinoma. The relative expression of IMP1, IMP2 and IMP3 varied among tumor types and only IMP1 was detected in all carcinoma in situ cells. Thus IMPs, and in particular IMP1, may be useful auxiliary markers of testicular neoplasia.

This article has been cited by other articles:

				J. A. Chao, Y. Patskovsky, V. Patel, M. Levy, S. C. Almo, and R. H. Singer ZBP1 recognition of {beta}-actin zipcode induces RNA looping Genes & Dev., January 15, 2010; 24(2): 148 - 158. [Abstract] [Full Text] [PDF]

				J. Christiansen, A. M Kolte, T. v O Hansen, and F. C Nielsen IGF2 mRNA-binding protein 2: biological function and putative role in type 2 diabetes J. Mol. Endocrinol., November 1, 2009; 43(5): 187 - 195. [Abstract] [Full Text] [PDF]

				A. Git, R. Allison, E. Perdiguero, A. R. Nebreda, E. Houliston, and N. Standart Vg1RBP phosphorylation by Erk2 MAP kinase correlates with the cortical release of Vg1 mRNA during meiotic maturation of Xenopus oocytes RNA, June 1, 2009; 15(6): 1121 - 1133. [Abstract] [Full Text] [PDF]

				K. Lapidus, J. Wyckoff, G. Mouneimne, M. Lorenz, L. Soon, J. S. Condeelis, and R. H. Singer ZBP1 enhances cell polarity and reduces chemotaxis J. Cell Sci., September 15, 2007; 120(18): 3173 - 3178. [Abstract] [Full Text] [PDF]

				T. D. Gallardo, G. B. John, L. Shirley, C. M. Contreras, E. A. Akbay, J. M. Haynie, S. E. Ward, M. J. Shidler, and D. H. Castrillon Genomewide Discovery and Classification of Candidate Ovarian Fertility Genes in the Mouse Genetics, September 1, 2007; 177(1): 179 - 194. [Abstract] [Full Text] [PDF]